NEW YORK, April 18, 2026 (GLOBE NEWSWIRE) —
WHY: Rosen Legislation Agency, a world investor rights regulation agency, reminds purchasers of frequent inventory of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, each dates inclusive (the “Class Period”), of the vital Might 5, 2026 lead plaintiff deadline.
SO WHAT: When you bought Soleno frequent inventory throughout the Class Interval you could be entitled to compensation with out fee of any out of pocket charges or prices via a contingency payment association.
WHY ROSEN LAW: We encourage traders to pick certified counsel with a monitor report of success in management roles. Usually, corporations issuing notices shouldn’t have comparable expertise, sources, or any significant peer recognition. Many of those corporations don’t really litigate securities class actions, however are merely middlemen that refer shoppers or accomplice with regulation corporations that really litigate the circumstances. Be clever in choosing counsel. The Rosen Legislation Agency represents traders all through the globe, concentrating its observe in securities class actions and shareholder by-product litigation. Rosen Legislation Agency has achieved, at the moment, the biggest ever securities class motion settlement in opposition to a Chinese language Firm. Rosen Legislation Agency was Ranked No. 1 by ISS Securities Class Motion Providers for variety of securities class motion settlements in 2017. The agency has been ranked within the high 4 annually since 2013 and has recovered a whole lot of tens of millions of {dollars} for traders. In 2019 alone the agency secured over $438 million for traders. In 2020, founding accomplice Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Lots of the agency’s attorneys have been acknowledged by Lawdragon and Tremendous Legal professionals.
DETAILS OF THE CASE: Based on the lawsuit, defendants made false and/or deceptive statements and/or didn’t disclose that: (1) the Soleno Part 3 scientific trial program for diazoxide choline extended-release tablets (“DCCR”) had systematically downplayed, misrepresented, and/or hid vital proof of security issues probably associated to the administration of DCCR, together with points associated to extra fluid retention in scientific trial contributors; (2) consequently, the administration of DCCR to deal with hyperphagia in people with Prader-Willi syndrome (“PWS”) posed materially larger security dangers than disclosed by Soleno or its executives; and (3) consequently, DCCR had materially decrease industrial viability and undisclosed dangers associated to the chance of serious and widespread opposed occasions after its industrial launch, together with dangers associated to affected person discontinuation charges, decrease affected person adoption, prescriber reluctance, opposed regulatory motion, and potential reputational and authorized fallout. When the true particulars entered the market, the lawsuit claims that traders suffered damages.
More Read
No Class Has Been Licensed. Till a category is licensed, you aren’t represented by counsel until you keep one. You could choose counsel of your selection. You may additionally stay an absent class member and do nothing at this level. An investor’s means to share in any potential future restoration will not be dependent upon serving as lead plaintiff.
Legal professional Promoting. Prior outcomes don’t assure the same final result.
——————————-
More Read
Contact Data:
